Total Payments
$1,986
2024 Payments
$251.98
Companies
21
Transactions
104
Medicare Patients
4,168
Medicare Billing
$681,536
Payment Breakdown by Category
Food & Beverage$1,795 (90.4%)
Education$191.20 (9.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,795 | 102 | 90.4% |
| Education | $191.20 | 2 | 9.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $300.03 | 6 | $0 (2021) |
| ABBVIE INC. | $290.32 | 24 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $250.25 | 17 | $0 (2019) |
| Amgen Inc. | $166.96 | 9 | $0 (2024) |
| UCB, Inc. | $166.72 | 8 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $161.09 | 9 | $0 (2021) |
| Lilly USA, LLC | $150.14 | 7 | $0 (2023) |
| Allergan, Inc. | $121.87 | 7 | $0 (2021) |
| Alexion Pharmaceuticals, Inc. | $82.59 | 1 | $0 (2020) |
| Lundbeck LLC | $69.14 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $251.98 | 22 | ABBVIE INC. ($215.02) |
| 2023 | $306.05 | 16 | Lilly USA, LLC ($126.89) |
| 2022 | $147.30 | 7 | ABBVIE INC. ($42.02) |
| 2021 | $348.74 | 18 | Novartis Pharmaceuticals Corporation ($85.02) |
| 2020 | $329.20 | 14 | Alexion Pharmaceuticals, Inc. ($82.59) |
| 2019 | $286.88 | 8 | Teva Pharmaceuticals USA, Inc. ($204.25) |
| 2018 | $130.29 | 5 | Supernus Pharmaceuticals, Inc. ($73.13) |
| 2017 | $185.93 | 14 | Supernus Pharmaceuticals, Inc. ($158.61) |
All Payment Transactions
104 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/20/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $5.18 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $29.33 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.02 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: NEUROSCIENCE | ||||||
| 06/21/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: NEUROSCIENCE | ||||||
| 06/07/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $9.26 | General |
| Category: NEUROSCIENCE | ||||||
| 06/06/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: Cardiology | ||||||
| 06/06/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $10.08 | General |
| Category: NEUROSCIENCE | ||||||
| 05/14/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.01 | General |
| Category: NEUROSCIENCE | ||||||
| 05/02/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $10.01 | General |
| Category: NEUROSCIENCE | ||||||
| 05/01/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.41 | General |
| Category: NEUROSCIENCE | ||||||
| 04/30/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: NEUROSCIENCE | ||||||
| 04/26/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.72 | General |
| Category: NEUROSCIENCE | ||||||
| 04/25/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $10.64 | General |
| Category: NEUROSCIENCE | ||||||
| 03/29/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.50 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/20/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $4.01 | General |
| Category: NEUROSCIENCE | ||||||
| 03/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: NEUROSCIENCE | ||||||
| 03/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $5.30 | General |
| Category: NEUROSCIENCE | ||||||
| 02/21/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.12 | General |
| Category: NEUROSCIENCE | ||||||
| 01/30/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.00 | General |
| Category: NEUROSCIENCE | ||||||
| 01/16/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.89 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2023 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $7.06 | General |
| Category: Neuroscience | ||||||
| 11/08/2023 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $7.60 | General |
| Category: Neuroscience | ||||||
| 08/07/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 984 | 16,403 | $781,678 | $195,453 |
| 2022 | 8 | 1,122 | 12,753 | $689,007 | $178,852 |
| 2021 | 8 | 1,062 | 10,973 | $628,079 | $170,837 |
| 2020 | 11 | 1,000 | 8,915 | $549,027 | $136,393 |
Total Patients
4,168
Total Services
49,044
Medicare Billing
$681,536
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 46 | 15,150 | $378,750 | $74,511 | 19.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 466 | 700 | $201,600 | $63,886 | 31.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 293 | 293 | $128,791 | $34,205 | 26.6% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 46 | 113 | $45,878 | $14,177 | 30.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 122 | 136 | $26,384 | $8,582 | 32.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 11 | 11 | $275.00 | $92.40 | 33.6% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 46 | 11,450 | $286,250 | $54,655 | 19.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 355 | 355 | $156,344 | $45,142 | 28.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 353 | 469 | $134,726 | $43,735 | 32.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 263 | 322 | $62,468 | $20,784 | 33.3% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 43 | 93 | $37,758 | $12,029 | 31.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 19 | 19 | $5,529 | $1,520 | 27.5% |
| 64405 | Injection of anesthetic agent and/or steroid into upper neck and back of head nerve | Office | 2022 | 17 | 19 | $5,282 | $909.71 | 17.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 26 | 26 | $650.00 | $77.31 | 11.9% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 35 | 9,650 | $241,250 | $46,779 | 19.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 337 | 445 | $128,160 | $44,856 | 35.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 302 | 302 | $132,138 | $38,998 | 29.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 295 | 414 | $80,088 | $26,837 | 33.5% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Office | 2021 | 35 | 83 | $33,698 | $10,987 | 32.6% |
| 64450 | Injection of anesthetic agent and/or steroid into other peripheral nerve or branch | Office | 2021 | 11 | 19 | $4,161 | $1,161 | 27.9% |
| 64405 | Injection of anesthetic agent and/or steroid into greater occipital nerve of upper neck and back of head | Office | 2021 | 18 | 28 | $7,784 | $1,124 | 14.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 29 | 32 | $800.00 | $96.00 | 12.0% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2020 | 33 | 7,600 | $190,000 | $36,429 | 19.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 308 | 503 | $97,582 | $28,976 | 29.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 233 | 233 | $102,281 | $28,340 | 27.7% |
About Vinod Abraham
Vinod Abraham is a Psychiatry healthcare provider based in Hollywood, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1457438350.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Vinod Abraham has received a total of $1,986 in payments from pharmaceutical and medical device companies, with $251.98 received in 2024. These payments were reported across 104 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($1,795).
As a Medicare-enrolled provider, Abraham has provided services to 4,168 Medicare beneficiaries, totaling 49,044 services with total Medicare billing of $681,536. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Hollywood, MD
- Active Since 11/01/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1457438350
Products in Payments
- TROKENDI XR (Drug) $192.74
- QULIPTA (Drug) $171.29
- AIMOVIG (Biological) $161.09
- Briviact (Drug) $151.71
- BOTOX (Biological) $113.67
- UBRELVY (Drug) $99.91
- Aimovig (Biological) $86.48
- Soliris (Drug) $82.59
- AJOVY (Drug) $70.21
- VYEPTI (Biological) $69.14
- OXTELLAR XR (Drug) $57.51
- Corlanor (Drug) $49.20
- NURTEC ODT (Drug) $39.70
- AMYVID (Drug) $39.45
- AVONEX (Biological) $38.78
- AJOVY (Biological) $38.62
- Repatha (Biological) $31.28
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) $25.77
- EMGALITY (Drug) $23.25
- TRELEGY ELLIPTA (Drug) $22.42
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Hollywood
Zina Meriden, Md, MD
Psychiatry — Payments: $52,834
Psychiatry $52,834
Dr. Ignacio Zabaleta, M.d, M.D
Psychiatry — Payments: $32,506
Psychiatry $32,506
Fernando Stern, Md Pa, MD PA
Psychiatry — Payments: $28,244
Psychiatry $28,244
Alexander Pushka, Md, MD
Psychiatry — Payments: $9,398
Psychiatry $9,398
Dr. Douglas Lanes, M.d, M.D
Psychiatry — Payments: $6,923
Psychiatry $6,923
Dr. Julio Ballestas, M.d, M.D
Psychiatry — Payments: $3,230
Psychiatry $3,230